Surgery can, in specific and measurable ways, promote the spread of cancer cells. Physical manipulation of a tumor during an operation shakes loose cancer cells into the bloodstream, the massive wound-healing response that follows temporarily suppresses the immune system, and removing a primary tumor can even release distant micro-metastases from a kind of biological dormancy. None of this means surgery is the wrong choice. For most solid tumors, removing the primary mass remains one of the most powerful tools in oncology, and the survival benefit dwarfs the risk of surgical dissemination. But the concern is not pure myth, and understanding the mechanisms helps explain why modern surgical oncology has evolved specific techniques, drug regimens, and timing strategies to minimize the danger.
Where the “Cutting on Cancer” Belief Comes From
The idea that operating on a tumor makes it spread is deeply rooted in public consciousness. A study of primary-care patients in the United States found that nearly all respondents had heard the belief that surgery and exposing cancer to air would hasten its spread, and most agreed with it.1PubMed Central. “Cutting” on cancer: attitudes about cancer spread and surgery among primary care patients in the U.S.A. Research into the origins of this belief in lung cancer specifically suggests it may trace back to early debates within the medical community about the risks of lung biopsies, high surgical morbidity in the early days of thoracic surgery, and the difficulty of staging cancer before operating.2Journal of the National Medical Association. “The Air Got to It:” Exploring a Belief About Surgery for Lung Cancer In that era, patients often went into surgery with cancer that had already spread undetectably, so worsening after surgery looked like the operation itself had caused the decline. Air exposure has nothing to do with it, but the broader intuition that surgery can disturb a tumor turns out to rest on real biology.
Tumor Manipulation Shakes Cancer Cells Loose
One of the most direct mechanisms is straightforward: physically handling a tumor during surgery releases cancer cells into the bloodstream. In an animal model using real-time monitoring, researchers found that simply applying pressure to a tumor increased the rate of circulating tumor cells from roughly 1 cell per 10 minutes to nearly 7 during the pressure and then to about 19 per 10 minutes in the hour after the pressure stopped.3PubMed Central. Real-time monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry The spike was not just during the handling but actually peaked afterward, suggesting the tissue disruption continued to shed cells once the manipulation ended.
Similar findings have been reported in human colorectal cancer surgery. Blood samples taken from veins draining the surgical site showed that the cumulative detection rate of tumor-cell markers increased significantly after the tumor was mobilized during the operation.4PubMed Central. Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancer These dislodged cells are not guaranteed to form metastases. Most circulating tumor cells die quickly in the bloodstream. But the more cells that enter circulation, the greater the statistical chance that some survive and seed elsewhere.
Mechanical Seeding at Wound and Port Sites
Beyond cells entering the bloodstream, cancer cells can physically implant at the site of the surgical wound itself. This is known as wound seeding or port-site metastasis. Case reports have documented it across cancer types. One well-known report described a patient with endometrial cancer who developed a recurrence in her abdominal wall, likely from tumor cells deposited in the incision during the original operation.5Gynecologic Oncology. Wound Seeding Associated with Endometrial Cancer A review across surgical specialties found that the most commonly seeded tumor types were carcinomas and adenocarcinomas, and that poorly differentiated tumors were more prone to seeding.6PubMed Central. Tumor seeding across specialties: a systematic review
Laparoscopic (keyhole) surgery introduced its own version of this problem. In mouse experiments, cancer cells were observed attaching to the injured tissue at port sites immediately after surgery, forming visible nodules within about a week.7PubMed. Development of port-site metastasis after pneumoperitoneum The physical trocar wound appeared to be a more important factor in port-site metastasis than the carbon dioxide gas used to inflate the abdomen during laparoscopy.8PubMed. Influence of trocar placement and CO(2) pneumoperitoneum on port site metastasis following laparoscopic tumor surgery
Even needle biopsies carry a version of this risk. A review of the literature on needle-tract seeding found a striking range of reported rates, from under 2% up to 17–38% depending on the type of needle, the number of passes, the interval between biopsy and surgery, and the tumor’s histology.9PubMed Central. Reducing the Risk of Needle Tract Seeding or Tumor Cell Dissemination during Needle Biopsy Procedures The wide variance makes clear that technique and context matter enormously. For most diagnostic biopsies the risk is considered very low, but it is not zero.
The Inflammatory Storm After Surgery
Surgery does not just displace tumor cells mechanically. It also triggers a body-wide inflammatory response that, ironically, can help those displaced cells survive and grow. Major surgery involves large wounds, and the body responds with a surge of immune activity aimed at healing the tissue. Part of that response involves neutrophils, a type of white blood cell, which release structures called neutrophil extracellular traps (NETs). These are web-like tangles of DNA designed to catch pathogens at wound sites, but they can also ensnare circulating tumor cells.10Cancer Research. Surgery for Cancer: A Trigger for Metastases
That trapping is not protective. The NETs essentially glue cancer cells to tissue at distant sites, and the inflammatory molecules embedded in the DNA strands promote tumor growth rather than killing the cells. Researchers have found that blocking NET formation after surgery powerfully inhibited the accelerated development of new metastatic disease that is otherwise seen in surgically manipulated organs.10Cancer Research. Surgery for Cancer: A Trigger for Metastases Clinical reports confirm that markers of NETosis are elevated in plasma after major surgeries, and these NETs circulate through blood and lymphatic systems throughout the body.11Experimental & Molecular Medicine. Tumor regionalization after surgery: Roles of the tumor microenvironment and neutrophil extracellular traps
Platelets and other components of the coagulation system pile on. Tissue damage from surgery activates both the immune and clotting systems, and while these responses are essential for wound healing, they can simultaneously promote tumor cell survival and migration.12Frontiers in Oncology. The emerging role of neutrophil extracellular traps in cancer: from lab to ward
The Postoperative Immune Dip
At the same time the inflammatory response ramps up in ways that help tumors, the immune system’s ability to destroy cancer cells drops. Natural killer (NK) cells are among the body’s most important defenses against circulating tumor cells, and surgery suppresses them. The postoperative environment directly weakens NK cell activity, creating a window during which escaped cancer cells are less likely to be eliminated.13PubMed Central. Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery This is not a theoretical worry. Researchers have described NK cells as critical mediators in the formation of metastasis after surgery, and the perioperative period as a particularly vulnerable time for new metastatic seeding.14PubMed Central. The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
The combination is what makes the postoperative period so dangerous: more tumor cells are in circulation, the inflammatory environment is actively helping those cells stick to distant tissues, and the immune cells that would normally destroy them are suppressed. It is a perfect storm that lasts days to weeks.
Removing the Primary Tumor Can Wake Up Dormant Metastases
One of the more counterintuitive risks is that removing the main tumor can actually accelerate the growth of tiny, previously dormant metastases elsewhere in the body. The primary tumor secretes both growth-promoting and growth-inhibiting signals into the bloodstream. Some of those inhibitors, particularly substances that block new blood vessel formation, are quite stable and can suppress the growth of distant micro-metastases that have not yet developed their own blood supply. When the primary tumor is surgically removed, those inhibitor levels drop, and the distant deposits can suddenly begin growing.15PubMed Central. Potential impact of invasive surgical procedures on primary tumor growth and metastasis This has been confirmed in animal experiments where primary tumor removal led to rapid metastatic growth, driven by the loss of circulating angiogenesis inhibitors.16PubMed. Radiation therapy to a primary tumor accelerates metastatic growth in mice
Wound healing adds another layer. Many of the molecular signals the body uses to repair surgical wounds overlap with signals that help dormant tumor cells reawaken and begin proliferating.17Surgical Oncology. The link between wound healing and escape from tumor dormancy Growth factors meant to rebuild tissue at the incision site circulate widely and do not distinguish between a healing wound and a cluster of sleeping cancer cells.
Surgical Techniques That Reduce Dissemination
Surgeons are not powerless against these mechanisms. One of the most studied approaches is the no-touch isolation technique, where the blood vessels supplying a tumor are tied off before the tumor is handled. In colorectal cancer, a study comparing conventional resection with this approach found that tumor-cell DNA appeared in the portal blood of about 73% of conventional-surgery patients during the operation, compared to only 14% of patients who received no-touch isolation.18Surgery. Evaluation of molecular detection of cancer cells in portal blood and the effects of surgical manipulation on cell shedding in patients with colorectal cancer In pancreatic cancer surgery, the difference was even starker: circulating tumor cell counts rose after resection in five of six patients who had standard surgery, compared to zero of six in the no-touch group.19JAMA Surgery. Reduced Dissemination of Circulating Tumor Cells With No-Touch Isolation Surgical Technique in Patients With Pancreatic Cancer
Pre-treatment with chemotherapy before surgery, known as neoadjuvant therapy, is another strategy. By shrinking the tumor and killing off some of its cells before any cutting begins, neoadjuvant chemotherapy can reduce both the risk of incomplete resection and the likelihood of tumor cell shedding during the operation.20BMC Cancer. Safety and feasibility of neoadjuvant chemotherapy as a surgical bridge for acute left-sided malignant colorectal obstruction: a retrospective study This is one reason oncologists increasingly recommend chemotherapy before, not only after, surgery for certain cancers.
What Happens in the Operating Room Beyond the Scalpel
The choice of anesthesia and pain management may also matter, though the evidence here is less settled. Agents used in general anesthesia can alter cytokine release and affect both immune function and the behavior of cancer cells, with effects that persist for weeks after the operation.21PubMed Central. Anesthesia and cancer recurrence: a narrative review Whether these laboratory findings translate into meaningful differences in recurrence rates remains unclear. A systematic review comparing intravenous anesthesia (typically propofol) with inhaled gas anesthesia found theoretical reasons to prefer one over the other based on their differing immune effects, but definitive clinical proof is still being pursued.22PubMed. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia
Regional anesthesia, such as epidural analgesia, has attracted interest because it reduces the need for opioids and volatile anesthetics, both of which have independent immunosuppressive properties. Some clinical and animal studies suggest that perioperative epidural analgesia could improve cancer outcomes by preserving immune function and dampening the inflammatory response.23PubMed Central. Effects of Perioperative Epidural Analgesia on Cancer Recurrence and Survival Large randomized trials to confirm this are ongoing.
Anti-inflammatory drugs given around the time of surgery show somewhat more consistent results. A meta-analysis of over 12,000 cancer patients found that perioperative use of NSAIDs was associated with about a 16% improvement in disease-free survival and a 22% improvement in overall survival.24PubMed Central. Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis The caveat is that most of those studies were retrospective, which limits confidence in the findings.25Journal of Pain Research. Perioperative Pain Management and Cancer Outcomes: A Narrative Review Still, the biological logic is sound: tamping down the surgery-induced inflammatory cascade could reduce the environment that helps stray tumor cells establish themselves.
Perioperative Stress As an Independent Factor
The psychological stress a patient experiences around the time of surgery appears to matter independently of the operation itself. In experimental models, a 48-hour window of stress exposure around the time of surgery consistently increased metastasis formation, regardless of the effects of the surgical procedure. Both a glucocorticoid blocker and a beta-blocker prevented this effect, pointing to the body’s stress hormones as the driving force.26PubMed Central. Perioperative psycho-behavioral stress promotes cancer metastasis beyond the impact of surgery: Neuroendocrine and tumor molecular mediating mechanisms A combination of propranolol and an anti-inflammatory drug counteracted the stress-induced changes in tumor biology, including shifts toward more aggressive cellular behavior. This line of research suggests that managing patient anxiety and stress hormones perioperatively is not just about comfort but may have oncological implications.
Why Surgery Still Overwhelmingly Favors the Patient
With all these mechanisms stacked up, you might wonder why anyone undergoes cancer surgery at all. The answer is that the benefit of removing the bulk of the tumor nearly always outweighs the risks of dissemination. Even in metastatic breast cancer, where the disease has already spread, a meta-analysis found that surgically removing the primary tumor was associated with a 37% reduction in the risk of death.27PubMed Central. Surgical treatment of the primary tumour improves the overall survival in patients with metastatic breast cancer: A systematic review and meta-analysis In lung cancer patients with bone metastases, those who underwent surgery had roughly triple the three-year survival rate of those who did not.28PubMed Central. Survival benefit of resection surgery for lung adenocarcinoma with bone metastases and a post-operative prognosis nomogram establishment and validation
A primary tumor is a factory for new cancer cells. Every day it remains in the body, it sheds cells, secretes growth signals, suppresses immune function locally, and competes with the body for resources. Removing it eliminates the largest source of new metastatic seeds, even if the act of removal briefly increases the risk in the ways described above. The perioperative window is dangerous, but a growing tumor that is left in place is more dangerous over time.
Which Tumors Are Most Prone to Surgical Seeding
Not all cancers carry equal risk. Across surgical specialties, the tumor types most commonly associated with seeding were carcinomas and adenocarcinomas, with poorly differentiated tumors showing a higher tendency to seed than well-differentiated ones.6PubMed Central. Tumor seeding across specialties: a systematic review Poorly differentiated means the cancer cells have lost more of their normal structure and behavior, making them more aggressive and less likely to stay anchored in place. For cancers like low-grade thyroid carcinoma or early-stage breast tumors that are well-differentiated, the risk of surgical seeding is very small. For aggressive, high-grade cancers in the peritoneum or pancreas, surgeons tend to exercise extra caution with specimen handling and wound protection.
The location of the tumor matters too. Cancers in the peritoneal cavity (the space containing the abdominal organs) are more prone to implantation-type spread because free-floating cancer cells can settle on exposed tissue surfaces. Tumors that are encapsulated by a fibrous shell are less risky to handle than those that grow with irregular, infiltrating borders. This is one reason biopsies and surgeries for certain liver and kidney tumors follow strict protocols about needle paths and specimen extraction.
How Patients Can Think About This
If you or someone you know is facing cancer surgery, the takeaway is not to avoid the operation. It is to understand that the perioperative period is biologically active, and modern oncology takes that seriously. Surgeons increasingly use no-touch techniques, protective wound barriers, and careful specimen handling. Oncologists consider neoadjuvant therapy to shrink tumors before they are disturbed. Anesthesiologists are investigating which drug combinations best preserve immune function. And the emerging research on stress management and anti-inflammatory drugs suggests even more levers to pull in the future. The folk belief that “cutting on cancer” spreads it is not entirely wrong in its instinct, but it misidentifies the villain. The problem is not the surgery. The problem is a set of biological responses that surgery triggers, and those responses are increasingly something medicine knows how to manage.